dc.creatorDizanzo, María Paula
dc.creatorBugnon Valdano, Marina Paula
dc.creatorBasukala, Om
dc.creatorBanks, Lawrence
dc.creatorGardiol, Daniela
dc.date2022-12-13T15:05:11Z
dc.date2022-12-13T15:05:11Z
dc.date2022-12
dc.date2022-12-13T15:05:11Z
dc.date2022-12-13T15:05:11Z
dc.date2022-12
dc.date.accessioned2023-08-30T21:17:29Z
dc.date.available2023-08-30T21:17:29Z
dc.identifier1471-2407
dc.identifierhttp://hdl.handle.net/2133/25026
dc.identifierhttp://hdl.handle.net/2133/25026
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8541922
dc.descriptionOncogenic Human Papillomaviruses (HPVs) base their transforming potential on the action of both E6 and E7 viral oncoproteins, which perform cooperative or antagonistic actions and thus interfere with a variety of relevant cellular targets. Among them, the expression of some PDZ-containing polarity proteins, as DLG1 and hScrib, is altered during the HPV life cycle and the consequent malignant transformation. Together with the well-established interference of E6 with PDZ proteins, we have recently shown that E7 viral oncoprotein is also responsible for the changes in abundance and localization of DLG1 observed in HPV-associated lesions. Given that the mechanisms involved remained only partially understood, we here thoroughly analyse the contribution of a crucial E7 post-translational modifcation: its CKII-dependent phosphorylation. Moreover, we extended our studies to hScrib, in order to investigate possible conserved regulatory events among diverse PDZ targets of HPV.
dc.descriptionFil: Dizanzo, María Paula. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Biología Molecular y Celular de Rosario (IBR-CONICET); Argentina.
dc.descriptionFil: Bugnon Valdano, Marina Paula. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Biología Molecular y Celular de Rosario (IBR-CONICET); Argentina.
dc.descriptionFil: Gardiol, Daniela. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Biología Molecular y Celular de Rosario (IBR-CONICET); Argentina.
dc.descriptionFil: Basukala,Om. International Centre for Genetic Engineering and Biotechnology. Tumour Virology Laboratory; Italy.
dc.descriptionFil: Banks, Lawrence. International Centre for Genetic Engineering and Biotechnology. Tumour Virology Laboratory; Italy.
dc.formatapplication/pdf
dc.languageeng
dc.publisherBMC
dc.relationhttps://doi.org/10.1186/s12885-022-10105-5
dc.relationhttps://bmccancer.biomedcentral.com/articles/10.1186/s12885-022-10105-5
dc.rightshttps://creativecommons.org/licenses/by/4.0/
dc.rightsDizanzo, María Paula
dc.rightsBugnon Valdano, Marina Paula
dc.rightsBasukala,Om
dc.rightsBanks, Lawrence
dc.rightsGardiol, Daniela
dc.rightsAttribution 4.0 International (CC BY 4.0)
dc.rightsopenAccess
dc.subjectHPV E7
dc.subjectCKII
dc.subjectPDZ
dc.subjectDLG1 hScrib
dc.titleNovel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression
dc.typeartículo
dc.typearticle


Este ítem pertenece a la siguiente institución